Download Sanguine's Latest Shareholder Letter
Sanguine Corporation's PHER-O2 is the second generation of the only blood supplement to achieve FDA approval.
Copyright 2006 Sanguine Corp.
Products
|
News
|
Management
|
Investors
|
About Us
